301 related articles for article (PubMed ID: 9292952)
1. Successful treatment of a patient with Graves' disease on hemodialysis complicated by antithyroid drug-induced granulocytopenia and angina pectoris.
Miyasaka Y; Yoshimura M; Tabata S; Shozu A; Nishikawa M; Iwasaka T; Inada M
Thyroid; 1997 Aug; 7(4):621-4. PubMed ID: 9292952
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia.
Tajiri J; Noguchi S; Okamura S; Morita M; Tamaru M; Murakami N; Niho Y
Arch Intern Med; 1993 Feb; 153(4):509-14. PubMed ID: 7679571
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia.
Tajiri J; Noguchi S; Murakami N
Thyroid; 1997 Aug; 7(4):575-8. PubMed ID: 9292945
[TBL] [Abstract][Full Text] [Related]
4. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
Dai W; Zhang J; Zhan Z; Xu B; Jin H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
[TBL] [Abstract][Full Text] [Related]
5. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
6. The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis.
Altunbas H; Yazicioglu G; Balci MK; Karayalçin U; Undar L
Int J Clin Pract; 1999; 53(5):396-7. PubMed ID: 10695110
[TBL] [Abstract][Full Text] [Related]
7. Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
Balkin MS; Buchholtz M; Ortiz J; Green AJ
Thyroid; 1993; 3(4):305-9. PubMed ID: 7509672
[TBL] [Abstract][Full Text] [Related]
8. Severe pancytopenia associated with antithyroid drugs in a patient with Graves' disease and chronic renal failure.
Macia M; Méndez M; Fernández J; Riverol A; Rios
Clin Nephrol; 1997 Feb; 47(2):129. PubMed ID: 9049463
[No Abstract] [Full Text] [Related]
9. Morning granulocytopenia in a case of Graves' disease.
Nakamura S; Isaji M; Ishimori M
Endocr J; 2001 Apr; 48(2):181-4. PubMed ID: 11456265
[TBL] [Abstract][Full Text] [Related]
10. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
Kubota S
Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
[TBL] [Abstract][Full Text] [Related]
11. [Granulocyte colony-stimulating factor treatment (G-CSF) of antithyroid drug-induced granulocytopenia: granulocyte count measurement after 4 hours of G-CSF injection is useful for the detection of recovery from granulocytopenia].
Tajiri J; Noguchi S; Morita M; Tamaru M; Murakami N
Nihon Naibunpi Gakkai Zasshi; 1994 Jun; 70(5):517-20. PubMed ID: 7525366
[TBL] [Abstract][Full Text] [Related]
12. A rare case of Graves' disease during regular hemodialysis.
Maruyama S; Ikarashi T; Soda S; Toya M; Okamura K; Hirayama S; Suzuki K; Hanyu O; Sakurabayashi T; Nakagawa O; Aizawa Y
Clin Exp Nephrol; 2004 Mar; 8(1):71-4. PubMed ID: 15067521
[TBL] [Abstract][Full Text] [Related]
13. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
Takata K; Kubota S; Fukata S; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of granulocyte colony-stimulating factor (G-CSF) in antithyroid drug-induced agranulocytosis.
Murakami Y; Sasaki I; Hiraiwa T; Arishima T; Ito M; Hanafusa T; Sakane S; Ohsawa N; Takamatsu J; Miyauchi A; Kuma K
Endocr J; 2004 Dec; 51(6):579-85. PubMed ID: 15644577
[TBL] [Abstract][Full Text] [Related]
15. [Change in serum G-CSF levels in patients with Graves' disease by treatment with methimazole].
Hara H; Ban Y; Sato R; Ishikawa N; Yoshimura H; Hisaoka T; Ito K
Nihon Naibunpi Gakkai Zasshi; 1992 Oct; 68(10):1121-9. PubMed ID: 1281122
[TBL] [Abstract][Full Text] [Related]
16. [Childhood Graves' disease].
Sasaki N; Sato K
Nihon Rinsho; 2006 Dec; 64(12):2308-11. PubMed ID: 17154097
[TBL] [Abstract][Full Text] [Related]
17. Treatment of antithyroid drug-induced agranulocytosis by granulocyte colony-stimulating factor: a case of primum non nocere.
Hirsch D; Luboshitz J; Blum I
Thyroid; 1999 Oct; 9(10):1033-5. PubMed ID: 10560960
[TBL] [Abstract][Full Text] [Related]
18. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease.
Watanabe N; Narimatsu H; Noh JY; Yamaguchi T; Kobayashi K; Kami M; Kunii Y; Mukasa K; Ito K; Ito K
J Clin Endocrinol Metab; 2012 Jan; 97(1):E49-53. PubMed ID: 22049174
[TBL] [Abstract][Full Text] [Related]
19. Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
Magner JA; Snyder DK
Thyroid; 1994; 4(3):295-6. PubMed ID: 7530522
[TBL] [Abstract][Full Text] [Related]
20. Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?
Tajiri J; Noguchi S
Thyroid; 2005 Mar; 15(3):292-7. PubMed ID: 15785251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
